Research Journal of Pharmacy and Technology

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

The effect of Morbid Obesity on the Liver Function Enzymes


Affiliations
1 Environmental Research and Studies Centers, Babylon University -51002, Iraq
2 Babylon Technical Institute, Al-Furat Al-Awsat Technical University, 51015, Hilla, Iraq
3 Chemistry Dept., College of Science, University of Babylon, Iraq, Hilla, Iraq
     

   Subscribe/Renew Journal


Background: The liver is the major organ in the body and it is considered as an important organ for protein manufacture and detoxification. Liver health is evaluated by study liver function (LFTs) which include TSB, AST, ALT and ALK. The current study is an attempt to understand the correlation between morbid obesity and liver function enzymes. Method: The research population consisted of 67 subjects that divided into two groups; morbidly obese group (41) and the control group (healthy appearance subjects) (26). The levels of serum liver enzymes activities (ALT, AST, ALK) and TSB were determined by suitable kits. Result: In current study no statistically significant differences were observed in AST, ALT and ALK levels between the two types of procedures. The highest differences were noted for TSB levels between obese and individual healthy. While there was an association between the BMI and both AST and ALT; there was no relationship between the body mass index BMI and TSB and ALK. Conclusion: This study showed a correlation between the BMI with AST and ALT of morbidly obese.

Keywords

Obesity, GPT, GOT, ALK, TSB.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Kasarala, G.; and Tillmann, H. L. Standard Liver Tests Clinical Liver Disease 2016; 8(1):13-18.

  • Maan W, Warsi AQ, Rashed A, Karjoo M. Unexplained High Activity of Aspartate Aminotransferase in an Asymptomatic Pediatric Patient. Int J Pediatr 2017; 5(10): 5805-5808

  • Mauro P, Renze B, Wouter W. Enzymes. In: Tietz text book of clinical chemistry and molecular diagnostics. Carl AB, Edward R, David EB. 4th edition, Elsevier 2006, 604-616.

  • Giannini EG, Testa R, Savarino V. Liver Enzyme Alteration: A Guide for Clinicians. CMAJ. 2005;172(3):367–79.

  • Lord R, Fahie-Wilson M, Suri S.A Paediatric Case of Macro Aspartate Aminotransferase. Ann Clin Biochem 2008; 45:323-4.

  • Yulia. A, Wijesiriwardana. A. Extremely High Isolated Maternal Alkaline Phosphatase Serum Concentration -2 Case Reports. Int J Pregn& Chi Birth 2017; 2(4): 00031

  • Salerno M, Di Maio S, Gasparini N, Rizzo M, Ferri P, Vajro P. Liver abnormalities in Turner syndrome. Eur J Pediatr. 1999;158(8):618-623.

  • Donaldson MD, Gault EJ, Tan KW, Dunger DB. Optimising management in Turner syndrome: from infancy to adult transfer. Arch Dis Child. 2006;91(6):513-520.

  • Meyer, R. E., Thompson, S.J., Addy, C.L., Garrison, C. Z., Best, R.G. Maternal serum placental alkaline phosphatase level and risk forpreterm delivery. Am J ObstetGynecol 1995;173(1): 181-186

  • Chang H-C, Yang H-C, Chang H-Y, Yeh C-J, Chen H-H, Huang K-C, et al. Morbid obesity in Taiwan: Prevalence, trends, associated social demographics, and lifestyle factors. PLoS ONE 2017; 12(2): e0169577. doi:10.1371/journal. pone.0169577

  • Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity.Annu Rev Immunol 2011;29: 415-45.

  • Swınburn BA, Caterson I, Seıdell JC, James WP. Diet, nutrition and the prevention of excess weight gain and obesity. Public Health Nutr 2004;7(1):123-46.

  • Álvarez-Castro P, Sangiao-Alvarellos S, Brandón-Sandá I, Cordido F. EndocrinaFuncion in obesity. EndocrinolNutr 2011;58(8):422-32.

  • World Health Organization. 2016. Obesity and overweight. Fact sheet No 311. Availableat http:// www.who.int/ mediacentre/ factsheets/ fs311/ en/ (accessed on September 2016).

  • Skinner, A. C; Ravanbakht,S. N ;Skelton J. A; Perrin E. M and Armstrong, S. C . Prevalence of Obesity and Severe Obesity in US Children, 1999–2016. Pediatrics. 2018;141(3): e20173459

  • Lonardo A, Bellentani S, Ratziu V et al. Insulin resistance in nonalcoholic steatohepatitis: necessary but not sufficient— death of a dogma from analysis of therapeutic studies? Exp Rev GastroenterolHepatol 2011; 5:279–89.

  • SalvaggioوA.; Periti, M.; Miano, L.; Tavanelli, M. and Marzorati, D. Body Mass Index and Liver Enzyme Activity in Serum CLINICALCHEMISTRY,1991. 37 (5): 720-723

  • Gómez, Z. S; Fernández, Q. A.; Lasa, A.; Hijona, E.; Bujanda, L. and Portillo M.P. Effects of resveratrol on obesity-related inflammation markers in adipose tissue of genetically obese rats. Nutrition. 2013; 29(11-12):1374-80.

  • Marchesini, G.; Brizi, M.; Bianchi, G.; Tomassetti, S.; Bugianesi, E.; Lenzi, M.; Mccullough, A.J.;Natale, S.; Forlani, G. and Melchionda N. Nonalcoholic fatty liver disease: a feature of metabolic syndrome. Diabetes. 2001;50(8):1884- 1850.

  • Alta’ee AH, Hadwan MH, Almashhedy LA. The balance between superoxide dismutase and catalase activi-ties in sera of obese Iraqi men. Euro Mediterranean Biomedical Journal. 2015;10(17):197-202.

  • Lee, J.K.; Shim, J.H. and Lee, H.C et al. Estimation of the healthy upper limits forserum alanine aminotransferase in Asian populations with normal liver histology. Hepatology2010; 51: 1577 – 83.

  • Nomura, F.; Ohnishi, K. and Satomura, Y. et al. Liver function in moderate obesity--study in 534 moderately obese subjects among 4613 male company employees. Int J Obes1986; 10: 349 – 54.

  • Wejstal, R.; Hansson, G. and Lindholm, A. et al. Persistent alanine amino transferase elevation in healthy Swedish blood donors--mainly caused by obesity. Vox Sang 1988 ; 55 : 152 – 6.

  • Piton, A.; Poynard, T .and Imbert-Bismut, F. et al. Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. MULTIVIRC Group. Hepatology1998; 27: 1213 – 9

  • Flores, Y.N.; Auslander, A.; Crespi, M.C.; Rodriguez, M.; Zhang, Z. F. and Durazo, F. et al.. Longitudinal association of obesity, metabolic syndrome and diabetes with risk of elevated aminotransferase levels in a cohort of Mexican health workers. Journal of digestive diseases. 2016; 17:304-12

  • Younossi, Z. M.; Stepanova, M.; Afendy, M.; Fang, Y.; Younossi,Y.; and Mir, H. et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association. 2011; 9:524-30.

  • Jayanta, P.; Raj Vigna, V.; Lorance, P.;, Shihaz, H.; Kula Naresh, K.S. and Mohit P. Shetti .Effects of lifestyle modification on liver enzyme and Fibroscan in Indian patients with non-alcoholic fatty liver.2018. disease Gastroenterology Report, 6(1):49–53

  • Rohania, F.; Golgiric, F.; Alaeid M. R., Karimie, M.; Nikraftarf, P. and Bozorgmehrf, R. Relationship Between Obesity and Liver Enzymes Levels in Turner’s Syndrome. Gastroenterol Res. 2017;10(1):28-32

  • Salerno M, Di Maio S, Gasparini N, Rizzo M, Ferri P, Vajro P. Liver abnormalities in Turner syndrome. Eur J Pediatr. 1999;158(8):618-623.

  • El-Mansoury, M.; Berntorp, K.; Bryman,I.; Hanson, C.; Innala, E.; Karlsson, A. and Landin-Wilhelmsen, K. Elevated liver enzymes in Turner syndrome during a 5-year follow-up study. ClinEndocrinol (Oxf). 2008;68(3):485-490.

  • Wasniewska, M.; Bergamaschi, R.; Matarazzo, P.; Predieri, B.; Bertelloni, S.; Petri, A.; Sposito, M. et al. Increased liver enzymes and hormonal therapies in girls and adolescents with Turner syndrome. J Endocrinol Invest. 2005;28(8):720-726.

  • Dufour, D.R.; Lott, J.A.; Nolte, F.S.; Gretch, D.R.; Koff, R.S. and Seeff, L.B. Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring. Clin Chem 2000; 46:2050–2068.

  • Dufour, D. R. Effects of habitual exercise on routine laboratory tests. Clin Chem 1998;44: A136.

  • Salerno, M.; Di Maio, S.; Gasparini, N.; Rizzo, M.; F erri, P. and Vajro, P. Liver abnormalities in Turner syndrome. Eur J Pediatr. 1999;158(8):618-623.

  • Donaldson, M.D.; Gault, E.J.; Tan, K. W. and Dunger, D.B.Optimising management in Turner syndrome: from infancy to adult transfer. Arch Dis Child. 2006;91(6):513-520.

  • Willems, A.; Paulson, TA.W.; Keil, M.; Brooke-Wavell, K .and Goosey-Tolfrey, V.L. Dual-Energy X-Ray Absorptiometry, Skinfold Thickness, and Waist Circumferencefor Assessing Body Composition in Ambulant and Non-Ambulant Wheelchair Games Players. Front. Physiol. (2015) 6:356

  • Demmer, D.L.; Beilin, L.J; Hands, B. Burrows, S.; Pennell, C.E; Lye, S.J.and et al. Dual Energy XRay Absorptiometry Compared with Anthropometry in Relation to Cardio-Metabolic Risk Factors in a Young Adult Population: Is the ‘Gold Standard’ Tarnished? PLoS ONE. (2016) .11(9): e0162164.


Abstract Views: 226

PDF Views: 0




  • The effect of Morbid Obesity on the Liver Function Enzymes

Abstract Views: 226  |  PDF Views: 0

Authors

Amera Kamal Mohammed
Environmental Research and Studies Centers, Babylon University -51002, Iraq
Thanaa Abdulmahdi Mokif
Babylon Technical Institute, Al-Furat Al-Awsat Technical University, 51015, Hilla, Iraq
Mahmoud Hussein Hadwan
Chemistry Dept., College of Science, University of Babylon, Iraq, Hilla, Iraq

Abstract


Background: The liver is the major organ in the body and it is considered as an important organ for protein manufacture and detoxification. Liver health is evaluated by study liver function (LFTs) which include TSB, AST, ALT and ALK. The current study is an attempt to understand the correlation between morbid obesity and liver function enzymes. Method: The research population consisted of 67 subjects that divided into two groups; morbidly obese group (41) and the control group (healthy appearance subjects) (26). The levels of serum liver enzymes activities (ALT, AST, ALK) and TSB were determined by suitable kits. Result: In current study no statistically significant differences were observed in AST, ALT and ALK levels between the two types of procedures. The highest differences were noted for TSB levels between obese and individual healthy. While there was an association between the BMI and both AST and ALT; there was no relationship between the body mass index BMI and TSB and ALK. Conclusion: This study showed a correlation between the BMI with AST and ALT of morbidly obese.

Keywords


Obesity, GPT, GOT, ALK, TSB.

References